Home   Contact Us   Sitemap

 API Products  Formulation Products
API Products :




Therapeutic Category


R0-CEP 2008-017-Rev 01
(JDMF No. 225MF10144)
DMF No. 21239 Antiurolithic
Glimepiride R0-CEP 2009-067-Rev 00 DMF No. 22565 Antidiabetic
Gliclazide R0-CEP 2010-202-Rev 00 Under Compilation
Alogliptin Benzoate Under Compilation DMF No. 30612
Quetiapine Fumarate R0-CEP 2014-279-Rev 00 Under Compilation Antipsychotic
Dorzolamide Hydrochloride R0-CEP 2011-015-Rev 00 DMF No. 23795 Antiglaucoma
Betaxolol Hydrochloride R0-CEP 2011-031-Rev 01 DMF No. 25301
Brimonidine Tartrate R0-CEP 2014-180-Rev 00 DMF No. 22166
Brinzolamide EUDMF Available DMF No. 28134
Olopatadine Hydrochloride EUDMF Available DMF No. 24106 Antihistaminic
Bromfenac Sodium Under Compilation DMF No. 25245 Antiinflammatory
Dicycloverine/Dicyclomine HCl R1-CEP 2008-281-Rev 02
(JDMF No. 226MF 10115)
DMF No. 22295 Antispasmodic
Febuxostat Under Compilation DMF No. 28834 Hyperuricemia
Lacosamide EUDMF Available DMF No.29476 Analgesic, Anticonvulsant
Besifloxacin Hydrochloride Under Compilation DMF No. 29303 Bacterial Conjunctivitis
Rasagiline Mesylate Under Compilation DMF No. 27634 Antiparkinsonian
Rasagiline Tartrate Under Compilation Under Compilation
Apixaban Under Compilation DMF No. 30613 Anticoagulant

Products For Emerging Markets



Therapeutic Category

Carvedilol Antihypertensive
Pregabalin Anticonvulsant
Chlorzoxazone Muscle Relaxant
Domperidone Antiemetic
Domperidone Maleate Antiemetic

Products Under Development



Therapeutic Category

Canagliflozin Antidiabetic
Rufinamide Anticonvulsant
Azelastine Hydrochloride Antihistaminic
Bepotastine Besilate
Moxifloxacin Hydrochloride Antibacterial
Mirabegron Urinary Incontinence
Neostigmine Methylsulfate Anticholinesterase
Posaconazole Antifungal

API Intermediates


Name of the Intermediate

Chemical Name


Olopatadine HCl intermediate (Isoxepac) 11-oxo-6,11-dihydrodibenz(b,e)- oxepin-2-acetic acid 55453-87-76
Brinzolamide intermediate (BCTS) 3-Bromoacetyl-5-chloro-2- thiophenesulfonamide 160982-11-6
Dorzolamide HCl intermediate (AMDA) N-[(6S)-2-(aminosulphonyl)-6- methyl-7,7-dioxido-5,6-dihydro-4H-thieno[2,2-b]thiopyran-4-yl] acetamide 147200-03-1
Glimepiride intermediate (ASPC) N-{2-[4-(aminosulfonyl)phenyl] ethyl}- 3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide 119018-29-0
(a)Products protected by valid patents are not offered for sale and/or will not be sold in countries where the sale of such products constitutes a patent infringement. However, the liability and/or final responsibility of the above products shall be at buyer's risk.
(b) Products that are under patent protection in India, are intended to be supplied solely for uses reasonably related to the development and submission of information, for regulatory purpose required under the relevant law in force in India, or in a country other than India, strictly according to the section 107A (a) of the Patent Act, 1970.